Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: based on e-mail reply

The early mover discounts did work. It is just that PTSC and TPL wasted a lot of that very cash on stupid choices for M/A in PTSC case, and TPL sunk 40 Million into intelisys. If we both had that cash today we would be in a much stronger position. We probably could have raised the dicounted rate significantly. Now everyone is just waiting for us to die a slow death. That is why this T3 case is so important to us. No more chances to screw this up. This is it.

Share
New Message
Please login to post a reply